Group 1 - A domestic robotics company is developing the world's first gestational robot, which simulates the uterine environment and replicates the entire human pregnancy experience from conception to delivery [1] - The technology currently involves a gestation chamber combined with a robotic body, with a prototype expected to be launched within a year, priced at no more than 100,000 yuan [1] - Supporters believe this technology could address challenges faced by women who are unable to conceive naturally due to health issues or life planning [1] Group 2 - Related A-share concept stocks include Meditech and Jiechang Drive [1]

Core Insights - The world's first "gestation robot" is being developed by Dr. Zhang Qifeng from Nanyang Technological University in Singapore, expected to be launched within a year at a price not exceeding 100,000 yuan [2][3] - This technology differs from traditional IVF and surrogacy by simulating the uterine environment within a humanoid robot, allowing for a full replication of the human experience from conception to delivery [2] - The motivation behind this innovation is to cater to the needs of modern young people who desire children but do not want to undergo pregnancy [2] Technology Overview - The current technology is based on a gestation chamber, which is integrated with a robotic system to create a "robotic womb" [3] - The prototype is anticipated to be available within a year, with a pricing strategy aimed at making it accessible at under 100,000 yuan [3] Market Reaction - The announcement has generated significant public interest, with the topic trending on social media platforms, accumulating over 80 million views on Weibo [2]